Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?
9
170Ṁ872026
71%
chance
1D
1W
1M
ALL
As implied in these tweets, among other places. Closes in 3 years.
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
1,000Related questions
Related questions
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
81% chance
Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
38% chance
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
86% chance
Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss
65% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
17% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
7% chance
What fraction of US adults will regularly take GLP-1 drugs in 2030?
Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
39% chance